SeaStar Medical Holding Corp (ICU) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US81256L3024
SeaStar Medical Holding Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 135,000.00 USD | 1.23 m USD |
| Gross profit | 135,000.00 USD | 1.18 m USD |
| Operating income | -17.84 m USD | -12.18 m USD |
| EBIT | -24.68 m USD | -12.44 m USD |
| Net income | -24.83 m USD | -12.15 m USD |
| Diluted EPS – continuing operations | -6.63 USD | – |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SeaStar Medical Holding Corp
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
More stocks
- Versus Systems Inc. (VS)
- Limitless X Holdings Inc. (LIMX)
- Oncotelic Therapeutics, Inc. (OTLC)
- Modular Medical, Inc. (MODD)
- Aclarion, Inc. (ACON)
- Birdie Win Corp (BRWC)
- RenX Enterprises Corp. (RENX)
- BLUM HOLDINGS, INC. (BLMH)
- Elme Communities (ELME)
- Longeveron Inc. (LGVN)
- BIO KEY INTERNATIONAL INC (BKYI)
- CYANOTECH CORP (CYAN)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.